Intravenous immunoglobulin protects neurons against amyloid beta-peptide toxicity and ischemic stroke by attenuating multiple cell death pathways

Mechanisms of action of intravenous immunoglobulins

(2011) Anne Baerenwaldt et al.   Expert Review of Clinical Immunology

Pathophysiology, treatment, and animal and cellular models of human ischemic stroke

(2011) Trent M Woodruff et al.   Molecular Neurodegeneration

Evidence that  -Secretase-Mediated Notch Signaling Induces Neuronal Cell Death via the Nuclear Factor- B-Bcl-2-Interacting Mediator of Cell Death Pathway in Ischemic Stroke

(2011) T. V. Arumugam et al.   MOLECULAR PHARMACOLOGY

Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway

(2011) Robert M. Anthony et al.   NATURE

Inhibition of JNK phosphorylation reverses memory deficit induced by β-amyloid (1–42) associated with decrease of apoptotic factors

(2010) Mahmoudreza Ramin et al.   BEHAVIOURAL BRAIN RESEARCH

The other side of immunoglobulin G: suppressor of inflammation

(2010) S. Aschermann et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease

(2010) Johanna Magga et al.   Journal of Neuroinflammation

N-stearoyltyrosine protects primary neurons from Aβ-induced apoptosis through modulating mitogen-activated protein kinase activity

(2010) Z.H. Yang et al.   NEUROSCIENCE

Intravenous immunoglobulins - understanding properties and mechanisms

(2009) A. Durandy et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders

(2009) Mark P. Mattson   EXPERIMENTAL GERONTOLOGY

Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science

(2009) Beatrix Kotlan et al.   Immunotherapy

Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway

(2009) Vanja Vukic et al.   NEUROBIOLOGY OF DISEASE

IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders

(2009) H. Fillit et al.   NEUROLOGY

Targeting p38 MAPK pathway for the treatment of Alzheimer's disease

(2009) Lenka Munoz et al.   NEUROPHARMACOLOGY

Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3β is required for tau aggregation

(2008) Naruhiko Sahara et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenal

(2008) Sung-Chun Tang et al.   EXPERIMENTAL NEUROLOGY

Ambivalent effect of immunoglobulins on the complement system: Activation versus inhibition

(2008) Milan Basta   MOLECULAR IMMUNOLOGY

18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease

(2008) Norman R. Relkin et al.   NEUROBIOLOGY OF AGING

Neuroprotection in stroke by complement inhibition and immunoglobulin therapy

(2008) T.V. Arumugam et al.   NEUROSCIENCE